Zidovudine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Azidothymidine; AZT

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

1 h

Pharmacodynamics (Effect)This section has been translated automatically.

Nucleoside analogue. Competitive inhibition of HIV reverse transcriptase in HIV infection.

IndicationThis section has been translated automatically.

Combination therapy of HIV infection.

Pregnancy/nursing periodThis section has been translated automatically.

Do not breastfeed while taking this medicine!

Dosage and method of useThis section has been translated automatically.

  • Peroral application (cps/filmbl./sg.): Adults: 500-600 mg/day divided into 2-3 EDs. Children > 3 months - 12 years 360-480 mg/m2 KO/day divided into 3-4 ED.
  • I.v. application: adults (70 kg): 1 or 2 mg/kg bw every 4 hours, children: 80-160 mg/m2 KO every 6 hours i.v.
  • Infants > 3 months: 12 mg/kg bw/day
  • infants < 3 months: 8 mg/kg bw/day

Remember! Men should not conceive children during AZT treatment and up to 6 months (e.g. as part of post-exposure prophylaxis) afterwards!

Undesirable effectsThis section has been translated automatically.

  • Cutaneous ADRs: erythroderma, maculopapular exanthema, urticaria, nail pigmentation.
  • Also: anemia, neutropenia, leukopenia, gastrointestinal problems, fever, headache, reaction limitation, paresthesias, proximal myopathies in long-term use.

    Notice! Increase of side effects with simultaneous administration of Cotrimoxazole and Pyrimethamine

    . Simultaneous administration of ganciclovir almost always results in myelosuppression, which can be corrected by administration of G-CSF!

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Cytostatic treatment of lymphoma or Kaposi's sarcoma, severe liver and kidney dysfunction.

PreparationsThis section has been translated automatically.

Retrovir

Note(s)This section has been translated automatically.

The effective level in the liquor is about 50% of the plasma level.

TablesThis section has been translated automatically.

Main interactions of zidovudine

Acetylsalicylic acid

Zidovudine toxicity ↑

Aciclovir

rarely seizures ↑

amphotericin B

Haematotoxicity ↑

Anti-inflammatories, non-steroidal

Zidovudine toxicity ↑

Atovaquon

Zidovudine plasma levels ↑ by 35%

Barbiturates

Zidovudine toxicity ↑

Cotrimoxazole

Myelosuppression ↑

Dapson

Myelosuppression ↑

Doxorubicin

Myelosuppression ↑

Etoposide

Myelosuppression ↑

Fluconazole

Zidovudine plasma mirror ↑

Flucytosine

Haematotoxicity ↑

Foscarnet

Anemia

Ganciclovir

Haematotoxicity ↑, avoid combination

Levomethadone

Zidovudine plasma mirror ↑

Pentamidine i.v.

rarely hematotoxicity ↑

Ribavirin

Ribavirin effect ↓

Rifabutin

Zidovudine plasma mirror ↓

Sulfonamides

Haematotoxicity ↑

Vinblastine

Haematotoxicity ↑

Vincrist

Haematotoxicity ↑

Authors

Last updated on: 29.10.2020